<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR73027</article-id>
      <title-group>
        <article-title>Synthesis, Characterization of Some Novel Pyrazoline incorporated Imidazo[1,2-a]pyridines for anti-inflammatory and anti-bacterial activities</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kishore</surname>
            <given-names>Bollam Nanda</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Unyala</surname>
            <given-names>Rishika</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Begum</surname>
            <given-names>Ameena</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hepsibha</surname>
            <given-names>Chirra</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reddy</surname>
            <given-names>B.Madhava</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Babu</surname>
            <given-names>V.Harinadha</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2017-06-01">
        <month>06</month>
        <day>01</day>
        <year>2017</year>
      </pub-date>
      <volume>7</volume>
      <issue>3</issue>
      <abstract>
        <p>Different phenacyl bromides were reacted with 2-amino pyridine to give 2-aryl imidazo[1,2-a] pyridines, which on subsequent reaction with Vilsmeier-Haack reagent gave 2-aryl imidazo[1,2-a] pyridine carbaldehydes (4a-4b). Claisen-Schmidt condensation of 4a and 4b with different substituted acetophenones afforded chalcones (5a-5f). The reaction of chalcones with phenyl hydrazine gave six new derivatives of pyrazolyl imidazo[1,2-a]pyridines (6a-6f ) in good yields. The synthesized compounds were characterised on the basis of physical and spectral data. The compounds were evaluated for anti-inflammatory and anti-bacterial activities. The compounds 6a, 6b, and 6c exhibited potent anti-inflammatory activity and results are comparable with standard drug, ibuprofen. None of the compounds showed any significant antimicrobial activity even at a concentration of 1000 µg/ml against Gram +ve and Gram –ve organisms.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Imidazo[1</kwd>
        <kwd>2-a] pyridine</kwd>
        <kwd>Pyrazoline</kwd>
        <kwd>Claisen-Schmidt condensation</kwd>
        <kwd>Chalcone</kwd>
        <kwd>Anti-inflammatory activity and Anti-bacterial activity.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
